Publication - Advice and guidance

Coronavirus (COVID-19) mRNA Vaccine BNT162b2 Pfizer/BioNTech: vaccine national protocol v2.3 - edition 2.3

Published: 23 Sep 2021

This protocol is for the supply and administration of COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows administration during or in anticipation of COVID-19 pandemic.

Coronavirus (COVID-19) mRNA Vaccine BNT162b2 Pfizer/BioNTech: vaccine national protocol v2.3 - edition 2.3
Reference no: COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine Protocol